Position in PVLA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$24,310,489
New position
Shares Held
195,030
first reported quarter
Ownership
1.36%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRIMECAP MANAGEMENT CO/CA/ holds $3,436,828,710 across 16 Biotechnology names. PVLA ranks #11 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
4,975,181 | $1,477,479,501 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
14,194,005 | $801,819,342 | |
| 3 | BNTX |
BioNTech SE
|
3,793,711 | $337,185,033 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
3,417,509 | $297,220,757 | |
| 5 | XNCR |
Xencor Inc
|
10,338,022 | $124,676,545 | |
| 6 | IMCR |
Immunocore Holdings plc
|
3,693,241 | $111,351,216 | |
| 7 | IMNM |
Immunome Inc.
|
4,788,231 | $104,718,611 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
569,180 | $42,267,306 |
All Filings in PVLA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,310,489 | 195,030 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||